Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines

Author： Scott Julie   Dorr Robert   Samulitis Betty   Landowski Terry  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.6, 2007-06, pp. : 749-757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells

By      

Molecular Medicine Reports, Vol. 7, Iss. 5, 2013-01 ,pp. : 1641-1645

Spandidos Publications

Access to resources Recommend Favorite

Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines

By Dorr Robert   Raymond Mary   Landowski Terry   Roman Nicholas   Fukushima Shoji  

International Journal of Gastrointestinal Cancer, Vol. 36, Iss. 1, 2005-08 ,pp. : 15-28

Humana Press, Inc

Access to resources Recommend Favorite

Growth Inhibition and Differentiation Induced by Peroxisome Proliferator Activated Receptor Gamma Ligand Rosiglitazone in Human Melanoma Cell Line A375

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 393-402

Humana Press, Inc

Access to resources Recommend Favorite

Extracts of centipede Scolopendra subspinipes mutilans induce cell cycle arrest and apoptosis in A375 human melanoma cells

By        

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 414-420

Spandidos Publications

Access to resources Recommend Favorite

Icariside II inhibits cell proliferation and induces cell cycle arrest through the ROSp38p53 signaling pathway in A375 human melanoma cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 410-416

Spandidos Publications

Access to resources Recommend Favorite